Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
11,88 USD | -0,17% | -10,14% | +33,48% |
16/04 | HIMS & HERS HEALTH, INC. : Jefferies & Co. is niet langer positief gestemd | ZM |
10/04 | HIMS & HERS HEALTH, INC. : Canaccord Genuity ontvangt een koopadvies | ZM |
Omzet 2024 * | 1,19 mld. 1,12 mld. | Omzet 2025 * | 1,47 mld. 1,38 mld. | Marktkapitalisatie | 2,55 mld. 2,39 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 24 mln. 22,53 mln. | Nettowinst (verlies) 2025 * | 52 mln. 48,81 mln. | EV/omzet 2024 * | 1,95 x |
Nettoliquiditeiten 2024 * | 218 mln. 205 mln. | Nettoliquiditeiten 2025 * | 382 mln. 359 mln. | EV/omzet 2025 * | 1,48 x |
K/w-verhouding 2024 * |
156
x | K/w-verhouding 2025 * |
53,1
x | Werknemers | 1.046 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 83,01% |
Recentste transcriptie over Hims & Hers Health, Inc.
1 dag | -0,17% | ||
1 week | -10,14% | ||
Lopende maand | -23,21% | ||
1 maand | -27,25% | ||
3 maanden | +36,71% | ||
6 maanden | +91,92% | ||
Lopend jaar | +33,48% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Andrew Dudum
CEO | Chief Executive Officer | 35 | 20-01-21 |
Oluyemi Okupe
DFI | Director of Finance/CFO | 57 | 24-01-22 |
Patrick Carroll
CTO | Chief Tech/Sci/R&D Officer | 66 | 01-01-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Delos Cosgrove
BRD | Director/Board Member | 82 | 20-01-21 |
Director/Board Member | 41 | 01-10-17 | |
Alex Bard
BRD | Director/Board Member | 49 | 20-01-21 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.95% | 11 M€ | -6,03% | - | |
0.02% | 237 M€ | -0,44% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 11,88 | -0,17% | 3 456 285 |
19-04-24 | 11,9 | -3,57% | 4 828 326 |
18-04-24 | 12,34 | -0,56% | 3 549 539 |
17-04-24 | 12,41 | -2,21% | 3 898 714 |
16-04-24 | 12,69 | -4,01% | 7 022 686 |
uitgestelde koers Nyse, 22 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+33,48% | 2,55 mld. | |
-38,28% | 2,2 mld. | |
+20,87% | 530 mln. | |
+42,77% | 467 mln. | |
-62,93% | 162 mln. |